Evaluation of a yeast-derived β-1,3/1,6-glucan preparation as a potential immunopotentiator for live La Sota Newcastle disease vaccination in broiler chickens
1,3-β-glucan as an immunopotentiator for NCD vaccine
DOI:
https://doi.org/10.62310/liab.v6i1.467Keywords:
β-glucan, Newcastle disease, La Sota vaccine, Immunopotentiator, Broiler chickenAbstract
Newcastle disease (ND) remains a constraint in vaccinated broiler chicken flocks, and practical immunopotentiators compatible with mass administration warrant evaluation. This exploratory study assessed short courses of a yeast-derived, water-dispersible preparation containing approximately 80% β-1,3/1,6-glucan in broilers receiving a single live La Sota vaccination. Three hundred day-old male Ross 308 chicks were allocated to five groups of 60 birds with four replicate pens per group: unvaccinated control (Control), vaccinated only (Vac), and vaccinated plus glucan at 0.5, 1, or 2 g/L in the drinking water (Vac β-Low, Vac β-Med, and Vac β-High, respectively). Glucan was administered on days 6–10, 21–22, and 28–29; the vaccine was administered by eye drop on day 7. Body weight, relative spleen, bursa, and thymus indices, hemagglutination-inhibition (HI) antibody titers; and 7-day survival following challenge on day 35 were recorded. The growth records showed an implausibly large increase between days 21 and 28 and could not be independently verified from the available data; consequently, the growth findings were presented as descriptive, and no claim of a growth effect or absence of a growth penalty was made. Exploratory organ index comparisons indicated that compared to Vac, Vac β-Med and Vac β-High had higher spleen indices on day 14, whereas only Vac β-High differed significantly from Vac on day 28. The age-wise analysis revealed that day-21 HI titer was higher in the Vac β-Med group than in the Vac group; whereas day-28 titers did not differ significantly. The day 42 samples were obtained from survivors only and therefore cannot be interpreted as an uncomplicated vaccine-response endpoint. The survival rates were 20%, 60%, 70%, 90%, and 80% in the control, Vac, Vac β-Low, Vac β-Med, and Vac β-High groups, respectively. The difference in the survival between Vac β-Med and Vac groups was 30 percentage points (approximate 95% CI: 2 to 52), but the exact odds ratio was imprecise (5.7, 95% CI: 0.9–64.6), and the comparison was not significant after the Holm adjustment (adjusted p = 0.19). Because each treatment was represented by a single challenge unit, bird-level survival comparisons are potentially pseudoreplicated. This study provides an exploratory signal for further testing but does not establish protection, an optimal dose, or an independent immunostimulatory mechanism.
Metrics
References
Aguilar JC, Rodríguez EG. (2007). Vaccine adjuvants revisited. Vaccine 25(19): 3752–3762. https://doi.org/10.1016/j.vaccine.2007.01.111
Bi S, Zhang J, Zhang L, Huang K, Li J, Cao L. (2022). Yeast cell wall upregulated cell-mediated immune responses to Newcastle disease virus vaccine. Poultry Science 101(4): 101712. https://doi.org/10.1016/j.psj.2022.101712
Brown GD, Gordon S. (2001). Immune recognition: a new receptor for β-glucans. Nature 413: 36–37. https://doi.org/10.1038/35092620
Dimitrov KM, Afonso CL, Yu Q, Miller PJ. (2017). Newcastle disease vaccines—a solved problem or a continuous challenge? Veterinary Microbiology 206: 126–136. https://doi.org/10.1016/j.vetmic.2016.12.019
Dimitrov KM, Abolnik C, Afonso CL, Albina E, Bahl J, Berg M, Briand FX, Brown IH, Choi KS, Chvala I, Diel DG, Durr PA, Ferreira HL, Fusaro A, Gil P, Goujgoulova GV, Grund C, Hicks JT, Joannis TM, Torchetti MK, Kolosov S, Lambrecht B, Lewis NS, Liu H, Liu H, McCullough S, Miller PJ, Monne I, Muller CP, Munir M, Reischak D, Sabra M, Samal SK, Servan de Almeida R, Shittu I, Snoeck CJ, Suarez DL, Van Borm S, Wang Z, Wong FYK. (2019). Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infection, Genetics and Evolution 74: 103917. https://doi.org/10.1016/j.meegid.2019.103917
Goodridge HS, Wolf AJ, Underhill DM. (2009). β-Glucan recognition by the innate immune system. Immunological Reviews 230(1): 38–50. https://doi.org/10.1111/j.1600-065X.2009.00793.x
Hashaam HM, Naveed S, Rehman S, Zeeshan M, Rahman A, Lokapirnasari WP, Hussain MA, Begum R, Jamal M, Yulianto AB. (2024). Impact of β-glucan with nonglucan biomaterials on growth performance, carcass characteristics, and viable count of lactobacilli in broiler chicks. Tropical Animal Science Journal 47(1): 53–60. https://doi.org/10.5398/tasj.2024.47.1.53
Holm S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 6: 65–70. https://doi.org/10.2307/4615733
Horst G, Levine R, Chick R, Hofacre C. (2019). Effects of beta-1,3-glucan (Aleta™) on vaccination response in broiler chickens. Poultry Science 98(4): 1643–1647. https://doi.org/10.3382/ps/pey523
Igwe AO, Ihedioha JI, Eze DC, Okoye JOA. (2020). Pullets had higher bursal and thymic weight indices and more antibody response to La Sota vaccination than broiler chickens (Gallus gallus domesticus). Veterinary Medicine and Science 6(3): 462–469. https://doi.org/10.1002/vms3.226
Kapczynski DR, King DJ. (2005). Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine 23(26): 3424–3433. https://doi.org/10.1016/j.vaccine.2005.01.140
Lazic SE. (2010). The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis? BMC Neuroscience 11: 5. https://doi.org/10.1186/1471-2202-11-5
Le TH, Le TB, Doan THT, Quyen DV, Le KXT, Pham VC, Nagataki M, Nomura H, Ikeue Y, Watanabe Y, Agatsuma T. (2011). The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines. Journal of Microbiology and Biotechnology 21(4): 405–411. https://doi.org/10.4014/jmb.1011.11024
Lebdah MA, Abdallah A, Hamouda EE, Elseddawy NM, ElBakrey RM. (2024). Protective effectiveness of two vaccination schemes against the prevalent Egyptian strain of Newcastle disease virus genotype VII. Open Veterinary Journal 14(1): 32–45. https://doi.org/10.5455/OVJ.2024.v14.i1.5
Miller PJ, Decanini EL, Afonso CL. (2010). Newcastle disease: evolution of genotypes and the related diagnostic challenges. Infection, Genetics and Evolution 10(1): 26–35. https://doi.org/10.1016/j.meegid.2009.09.012
Muthusamy G, Joardar SN, Samanta I, Isore DP, Roy B, Maiti TK. (2020). Dietary administered purified β-glucan of edible mushroom (Pleurotus florida) provides immunostimulation and protection in broiler experimentally challenged with virulent Newcastle disease virus. Journal of Basic and Applied Zoology 81: 55. https://doi.org/10.1186/s41936-020-00180-0
Netea MG, Joosten LAB, Latz E, Mills KHG, Natoli G, Stunnenberg HG, O’Neill LAJ, Xavier RJ. (2016). Trained immunity: a program of innate immune memory in health and disease. Science 352: aaf1098. https://doi.org/10.1126/science.aaf1098
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Würbel H. (2020). The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLOS Biology 18(7): e3000410. https://doi.org/10.1371/journal.pbio.3000410
Quintin J, Saeed S, Martens JHA, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, Jacobs L, Jansen T, Kullberg BJ, Wijmenga C, Joosten LAB, Xavier RJ, van der Meer JWM, Stunnenberg HG, Netea MG. (2012). Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host & Microbe 12(2): 223–232. https://doi.org/10.1016/j.chom.2012.06.006
Sultan HA, Talaat S, Elfeil WK, Selim K, Kutkat MA, Amer SA, Choi KS. (2020). Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers. Poultry Science 99(3): 1275–1286. https://doi.org/10.1016/j.psj.2019.10.063
Tamam SM, El-Kady MF, El Sawah AA, Okasha A. (2010). Immunomodulating effect of β-glucans and mannan oligosaccharide on broiler chicks vaccinated with Newcastle disease virus. Journal of Veterinary Medical Research 20(1): 296–302. https://doi.org/10.21608/jvmr.2020.77626
Vrdoljak A, Halas M, Süli T. (2017). Vaccination of broilers against Newcastle disease in the presence of maternally derived antibodies. Tierärztliche Praxis Ausgabe G: Großtiere/Nutztiere 45(3): 151–158. https://doi.org/10.15653/TPG-160661
Walachowski S, Tabouret G, Fabre M, Foucras G. (2017). Molecular analysis of a short-term model of β-glucan-trained immunity highlights the accessory contribution of GM-CSF to the priming of the mouse macrophage response. Frontiers in Immunology 8: 1089. https://doi.org/10.3389/fimmu.2017.01089
Wang M, Meng X, Yang R, Qin T, Li Y, Zhang L, Fei C, Zhen W, Zhang K, Wang X, Hu Y, Xue F. (2013). Cordyceps militaris polysaccharides can improve the immune efficacy of Newcastle disease vaccine in chicken. International Journal of Biological Macromolecules 59: 178–183. https://doi.org/10.1016/j.ijbiomac.2013.04.007
WOAH (World Organisation for Animal Health). (2021). Newcastle disease (infection with Newcastle disease virus). In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. WOAH, Paris, France. https://www.woah.org/en/what-we-do/standards/codes-and-manuals/
Wu Y, Li N, Zhang T, Che Y, Duan K, Wang Y, Zhou H, Wan X, Lei H, Nguyễn AD, De Souza C, Li K, Wu Y, Liu J, Wang D. (2022). Glycyrrhiza polysaccharides can improve and prolong the response of chickens to the Newcastle disease vaccine. Poultry Science 101(1): 101549. https://doi.org/10.1016/j.psj.2021.101549
Zhao X, Sun W, Zhang S, Meng G, Qi C, Fan W, Wang Y, Liu J. (2016). The immune adjuvant response of polysaccharides from Atractylodis macrocephalae Koidz in chickens vaccinated against Newcastle disease. Carbohydrate Polymers 141: 190–196. https://doi.org/10.1016/j.carbpol.2016.01.013
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Wesam Alqwidi, Mohamed A. Marzok, Mahmoud Mohamed, Ibrahim El-Sabagh, Mohamed El-Sherif, Mohammed Abdel Hafez, Mohamed Mohamed, Mohamed Soliman

This work is licensed under a Creative Commons Attribution 4.0 International License.
Accepted 2026-11-02
Published 2026-11-17